Annual SG&A
$37.87 M
+$736.40 K+1.98%
31 December 2023
Summary:
Cytosorbents annual selling, general & administrative expenses is currently $37.87 million, with the most recent change of +$736.40 thousand (+1.98%) on 31 December 2023. During the last 3 years, it has risen by +$6.36 million (+20.18%). CTSO annual SG&A is now -1.58% below its all-time high of $38.48 million, reached on 31 December 2021.CTSO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$7.83 M
-$575.30 K-6.85%
30 September 2024
Summary:
Cytosorbents quarterly selling, general & administrative expenses is currently $7.83 million, with the most recent change of -$575.30 thousand (-6.85%) on 30 September 2024. Over the past year, it has dropped by -$1.38 million (-15.00%). CTSO quarterly SG&A is now -29.39% below its all-time high of $11.08 million, reached on 31 December 2021.CTSO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.16 B
-$18.67 M-1.64%
30 September 2024
Summary:
Cytosorbents TTM selling, general & administrative expenses is currently -$1.16 billion, with the most recent change of -$18.67 million (-1.64%) on 30 September 2024. Over the past year, it has dropped by -$1.20 billion (-3324.93%). CTSO TTM SG&A is now -645980.84% below its all-time high of $40.03 million, reached on 31 March 2022.CTSO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.0% | -15.0% | -3324.9% |
| 3 y3 years | +20.2% | -7.3% | -3253.6% |
| 5 y5 years | +65.5% | +14.4% | -4849.3% |
CTSO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.6% | +20.2% | -29.4% | at low | -42.3% | at low |
| 5 y | 5 years | -1.6% | +65.5% | -29.4% | +14.5% | -64.1% | at low |
| alltime | all time | -1.6% | +3454.8% | -29.4% | >+9999.0% | <-9999.0% | at low |
Cytosorbents Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.83 M(-6.8%) | $36.03 M(-3.7%) |
| June 2024 | - | $8.40 M(-9.1%) | $37.41 M(-1.3%) |
| Mar 2024 | - | $9.25 M(-12.4%) | $37.92 M(+0.3%) |
| Dec 2023 | $37.87 M(+2.0%) | $10.56 M(+14.6%) | $37.81 M(+5.1%) |
| Sept 2023 | - | $9.21 M(+3.4%) | $35.96 M(-0.4%) |
| June 2023 | - | $8.91 M(-2.4%) | $36.10 M(-0.6%) |
| Mar 2023 | - | $9.13 M(+4.8%) | $36.31 M(-2.2%) |
| Dec 2022 | $37.14 M(-3.5%) | $8.71 M(-6.8%) | $37.14 M(-6.0%) |
| Sept 2022 | - | $9.34 M(+2.5%) | $39.51 M(+2.3%) |
| June 2022 | - | $9.12 M(-8.5%) | $38.61 M(-3.5%) |
| Mar 2022 | - | $9.96 M(-10.1%) | $40.03 M(+4.0%) |
| Dec 2021 | $38.48 M(+22.1%) | $11.08 M(+31.3%) | $38.48 M(+4.6%) |
| Sept 2021 | - | $8.44 M(-19.9%) | $36.77 M(+1.6%) |
| June 2021 | - | $10.54 M(+25.2%) | $36.20 M(+9.4%) |
| Mar 2021 | - | $8.42 M(-10.2%) | $33.09 M(+5.0%) |
| Dec 2020 | $31.51 M(+28.8%) | $9.38 M(+19.3%) | $31.51 M(+7.4%) |
| Sept 2020 | - | $7.86 M(+5.7%) | $29.34 M(+3.6%) |
| June 2020 | - | $7.44 M(+8.8%) | $28.32 M(+9.0%) |
| Mar 2020 | - | $6.84 M(-5.2%) | $25.98 M(+6.2%) |
| Dec 2019 | $24.47 M(+7.0%) | $7.21 M(+5.4%) | $24.47 M(+0.2%) |
| Sept 2019 | - | $6.84 M(+34.2%) | $24.42 M(+10.8%) |
| June 2019 | - | $5.10 M(-4.2%) | $22.04 M(-6.3%) |
| Mar 2019 | - | $5.32 M(-25.7%) | $23.52 M(+2.6%) |
| Dec 2018 | $22.88 M(+40.7%) | $7.16 M(+60.6%) | $22.93 M(+7.7%) |
| Sept 2018 | - | $4.46 M(-32.3%) | $21.29 M(+3.1%) |
| June 2018 | - | $6.58 M(+39.1%) | $20.65 M(+14.6%) |
| Mar 2018 | - | $4.73 M(-14.3%) | $18.02 M(+11.0%) |
| Dec 2017 | $16.25 M(+25.1%) | $5.52 M(+44.8%) | $16.24 M(+0.7%) |
| Sept 2017 | - | $3.81 M(-3.6%) | $16.12 M(+9.5%) |
| June 2017 | - | $3.96 M(+34.3%) | $14.73 M(+7.4%) |
| Mar 2017 | - | $2.95 M(-45.5%) | $13.72 M(+5.6%) |
| Dec 2016 | $12.99 M(+62.2%) | $5.40 M(+123.3%) | $12.99 M(+30.5%) |
| Sept 2016 | - | $2.42 M(-17.8%) | $9.96 M(+4.5%) |
| June 2016 | - | $2.94 M(+32.4%) | $9.53 M(+12.0%) |
| Mar 2016 | - | $2.22 M(-6.0%) | $8.51 M(+6.2%) |
| Dec 2015 | $8.01 M | $2.37 M(+19.1%) | $8.01 M(-1.4%) |
| Sept 2015 | - | $1.99 M(+3.4%) | $8.12 M(+9.4%) |
| June 2015 | - | $1.92 M(+11.2%) | $7.42 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $1.73 M(-30.2%) | $6.88 M(+6.4%) |
| Dec 2014 | $6.45 M(+85.1%) | $2.48 M(+92.3%) | $6.46 M(+29.4%) |
| Sept 2014 | - | $1.29 M(-6.2%) | $4.99 M(+9.8%) |
| June 2014 | - | $1.37 M(+4.4%) | $4.55 M(+14.7%) |
| Mar 2014 | - | $1.32 M(+30.0%) | $3.97 M(+13.8%) |
| Dec 2013 | $3.49 M(+75.9%) | $1.01 M(+19.8%) | $3.49 M(+10.5%) |
| Sept 2013 | - | $845.70 K(+7.0%) | $3.15 M(+11.9%) |
| June 2013 | - | $790.60 K(-5.4%) | $2.82 M(+17.7%) |
| Mar 2013 | - | $835.90 K(+22.7%) | $2.39 M(+20.4%) |
| Dec 2012 | $1.98 M(+26.0%) | $681.00 K(+33.4%) | $1.99 M(+10.1%) |
| Sept 2012 | - | $510.40 K(+39.2%) | $1.81 M(+3.7%) |
| June 2012 | - | $366.70 K(-14.9%) | $1.74 M(+6.6%) |
| Mar 2012 | - | $430.80 K(-13.5%) | $1.63 M(+3.9%) |
| Dec 2011 | $1.57 M(+47.5%) | $498.10 K(+11.7%) | $1.57 M(+23.0%) |
| Sept 2011 | - | $446.10 K(+72.0%) | $1.28 M(+17.6%) |
| June 2011 | - | $259.30 K(-29.8%) | $1.09 M(-5.4%) |
| Mar 2011 | - | $369.30 K(+81.0%) | $1.15 M(+7.8%) |
| Dec 2010 | $1.07 M(+0.1%) | $204.00 K(-19.9%) | $1.07 M(-0.4%) |
| Sept 2010 | - | $254.60 K(-20.8%) | $1.07 M(-4.7%) |
| June 2010 | - | $321.50 K(+12.2%) | $1.12 M(+4.6%) |
| Mar 2010 | - | $286.60 K(+37.4%) | $1.07 M(+0.9%) |
| Dec 2009 | $1.07 M(-15.5%) | $208.60 K(-32.3%) | $1.07 M(-8.6%) |
| Sept 2009 | - | $307.90 K(+13.2%) | $1.17 M(+2.8%) |
| June 2009 | - | $271.90 K(-1.9%) | $1.13 M(-9.0%) |
| Mar 2009 | - | $277.10 K(-10.4%) | $1.25 M(-1.1%) |
| Dec 2008 | $1.26 M(-23.6%) | $309.40 K(+12.1%) | $1.26 M(+3.3%) |
| Sept 2008 | - | $276.00 K(-28.1%) | $1.22 M(+2.4%) |
| June 2008 | - | $383.90 K(+31.7%) | $1.19 M(+5.7%) |
| Mar 2008 | - | $291.40 K(+8.4%) | $1.13 M(-31.7%) |
| Dec 2007 | $1.65 M(-10.8%) | $268.80 K(+8.4%) | $1.65 M(-14.1%) |
| Sept 2007 | - | $247.90 K(-22.4%) | $1.92 M(-7.6%) |
| June 2007 | - | $319.50 K(-60.8%) | $2.08 M(-2.9%) |
| Mar 2007 | - | $814.90 K(+50.7%) | $2.14 M(+60.2%) |
| Dec 2006 | $1.85 M | $540.60 K(+33.1%) | $1.34 M(+65.3%) |
| Sept 2006 | - | $406.30 K(+6.3%) | $810.00 K(-12.5%) |
| June 2006 | - | $382.20 K(+3923.2%) | $926.00 K(+70.3%) |
| Feb 2006 | - | $9500.00(-20.8%) | $543.80 K(+1.8%) |
| Nov 2005 | - | $12.00 K(-97.7%) | $534.30 K(+2.3%) |
| Aug 2005 | - | $522.30 K | $522.30 K |
FAQ
- What is Cytosorbents annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cytosorbents?
- What is Cytosorbents annual SG&A year-on-year change?
- What is Cytosorbents quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cytosorbents?
- What is Cytosorbents quarterly SG&A year-on-year change?
- What is Cytosorbents TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cytosorbents?
- What is Cytosorbents TTM SG&A year-on-year change?
What is Cytosorbents annual selling, general & administrative expenses?
The current annual SG&A of CTSO is $37.87 M
What is the all time high annual SG&A for Cytosorbents?
Cytosorbents all-time high annual selling, general & administrative expenses is $38.48 M
What is Cytosorbents annual SG&A year-on-year change?
Over the past year, CTSO annual selling, general & administrative expenses has changed by +$736.40 K (+1.98%)
What is Cytosorbents quarterly selling, general & administrative expenses?
The current quarterly SG&A of CTSO is $7.83 M
What is the all time high quarterly SG&A for Cytosorbents?
Cytosorbents all-time high quarterly selling, general & administrative expenses is $11.08 M
What is Cytosorbents quarterly SG&A year-on-year change?
Over the past year, CTSO quarterly selling, general & administrative expenses has changed by -$1.38 M (-15.00%)
What is Cytosorbents TTM selling, general & administrative expenses?
The current TTM SG&A of CTSO is -$1.16 B
What is the all time high TTM SG&A for Cytosorbents?
Cytosorbents all-time high TTM selling, general & administrative expenses is $40.03 M
What is Cytosorbents TTM SG&A year-on-year change?
Over the past year, CTSO TTM selling, general & administrative expenses has changed by -$1.20 B (-3324.93%)